Evidence map›Paper›PMID 36675608›Full record

ArticleJournal of clinical medicine2023

Compliance to Multidisciplinary Lifestyle Intervention Decreases Blood Pressure in Patients with Resistant Hypertension: A Cross-Sectional Pilot Study.

Eugenia Espinel, María Antonia Azancot, Alba Gomez, Anna Beneria, Anna Caraben, Laura Andurell, Pilar Delgado, Helena Castañé, Jorge Joven, Daniel Seron

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Eugenia EspinelDepartment of Nephrology, Hospital Universitari de la Vall d'Hebrón, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
María Antonia AzancotDepartment of Nephrology, Hospital Universitari de la Vall d'Hebrón, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
Alba GomezDepartment of Physical Medicine and Rehabilitation, Hospital Universitari de la Vall d'Hebrón, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
Anna BeneriaDepartment of Psychiatry, Hospital Universitari de la Vall d'Hebrón, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.ORCID 0000-0002-3575-4107
Anna CarabenDepartment of Nephrology, Hospital Universitari de la Vall d'Hebrón, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
Laura AndurellDepartment of Endocrinology and Nutrition, Hospital Universitari de la Vall d'Hebrón, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
Pilar DelgadoDepartment of Neurology, Hospital Universitari de la Vall d'Hebrón, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.ORCID 0000-0002-1628-4488
Helena CastañéUnitat de Recerca Biomèdica, Hospital Universitari de Sant Joan, Institut d'Investigació Sanitària Pere Virgili, Universitat Rovira i Virgili, 43201 Reus, Spain.
Jorge JovenUnitat de Recerca Biomèdica, Hospital Universitari de Sant Joan, Institut d'Investigació Sanitària Pere Virgili, Universitat Rovira i Virgili, 43201 Reus, Spain.ORCID 0000-0003-2749-4541
Daniel SeronDepartment of Nephrology, Hospital Universitari de la Vall d'Hebrón, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.ORCID 0000-0003-2054-653X
Universitat Autònoma de Barcelona · ESInstitut de Recerca Biomèdica Catalunya Sud · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypertension is a common chronic medical condition. Treatment is not satisfactory in a significant proportion of patients with primary hypertension, despite the concurrent use of three or more medications with different mechanisms of action. Such treatment-resistant hypertension is a clinical challenge associated with poor prognosis and needs further investigation. The efficacy of lifestyle changes has not been established yet in patients with resistant hypertension, and educational efforts appear clinically irrelevant in patients who must achieve behavioral changes without supervision. A 6-month multidisciplinary pilot intervention enrolled 50 patients with established resistant hypertension. The aims were: (1) to examine whether intensive and supervised lifestyle changes contribute to decreasing blood pressure in this condition, and (2) to identify which components affect compliance and feasibility. The program provided intensive changes in nutrition, physical exercise, and control of sleep disturbances supervised by nutritionists, physiotherapists, and psychologists. Nurses and pharmacists followed up on adherence to the antihypertensive medication. The primary outcome was 24 h blood pressure control. Data in patients with full compliance (n = 30) indicate that lifestyle modifications in resistant hypertension significantly reduced 24 h both systolic and diastolic blood pressure (p < 0.01), body mass index (p < 0.01), medication burden (p = 0.04), improving physical fitness, and cardiovascular risk markers such as heart rate (p = 0.01) and augmentation index (p = 0.02). The adherence to the intervention was moderate, with an attrition rate of 12%. A modified version reducing visits and explorations will likely improve compliance and can be used to assess the long-term maintenance of these benefits in managing resistant hypertension by diverse healthcare providers.

Indexed as

hypertensiontherapeuticsweight management

Identifiers

PMID36675608
PMCPMC9867179
OpenAlexW4316467090

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.